Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Patient safety

Authorisation status

ATC code

Species

Marketing authorisation date

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

Medicine type

Therapeutic area

Last updated

First published

58 results

Sort by

List item

Human medicine European public assessment report (EPAR): Xigris

drotrecogin alfa (activated), Sepsis; Multiple Organ Failure
Date of authorisation: 22/08/2002, , Revision: 13, Withdrawn, Last updated: 21/02/2012
List item

Human medicine European public assessment report (EPAR): Filgrastim ratiopharm

filgrastim, Neutropenia; Hematopoietic Stem Cell Transplantation; Cancer
Date of authorisation: 15/09/2008, , Revision: 1, Withdrawn, Last updated: 20/07/2011
List item

Human medicine European public assessment report (EPAR): Onsenal

Celecoxib, Adenomatous Polyposis Coli
Date of authorisation: 17/10/2003, , Revision: 13, Withdrawn, Last updated: 06/04/2011
List item

Veterinary medicine European public assessment report (EPAR): Nobilis Influenza H5N6

inactivated whole avian influenza virus antigen of H5 subtype (strain H5N6, A/duck/Potsdam/2243/84), Chicken
Date of authorisation: 31/01/2008, , , Revision: 1, Withdrawn, Last updated: 26/07/2010
List item

Veterinary medicine European public assessment report (EPAR): Nobilis Influenza H7N1

inactivated whole avian influenza virus antigen of H7N1 subtype (strain, A/CK/Italy/473/99), Chicken; Ducks
Date of authorisation: 14/05/2007, , , Revision: 2, Withdrawn, Last updated: 26/07/2010
List item

Human medicine European public assessment report (EPAR): Duzallo

allopurinol, lesinurad, Gout
Date of authorisation: 23/08/2018, , Revision: 2, Withdrawn, Last updated: 06/08/2020
List item

Human medicine European public assessment report (EPAR): Qutavina

teriparatide, Osteoporosis
Date of authorisation: 27/08/2020, , Withdrawn, Last updated: 18/01/2021
List item

Human medicine European public assessment report (EPAR): Lextemy

bevacizumab, Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms ,
Withdrawn, Last updated: 24/02/2021